BioPhoT offers life science teams the unique opportunity to work with one of Switzerland's leading business development experts, Marco Rüedi.
His expertise focuses on the strategic development and commercialization of life science innovations. Marco works closely with biotechnology, medical technology, and health innovation teams,helping them define clear development pathways from scientific results to market entry and investment readiness.
During the workshop, teams will receive industry-specific, hands-on feedback on their project's development logic, market potential and next steps, based on the experience of the Swiss life sciences ecosystem.
Teams are invited to register by 28 March. Places are limited!
The workshops are scheduled for 13-17 April 2026.
The programme will be organised in thematic days, each day focusing on a specific sub-discipline of life sciences and bringing together teams from that area.
Provisional breakdown:
Day 1 - Enabling Technologies
Day 2 - Biotechnology / Pharmaceuticals / Synthetic Molecules / Nutraceuticals
Day 3 - Medical Technologies (MedTech)
Day 4 - Diagnostics
Day 5 - Diagnostics II
*Detailed programme and organisational information will be sent before the event. A second workshop session is planned for September 2026.
Why participate?
- Sector expertise. He specialises in business development for life science projects.
- Swiss ecosystem perspective. Insights from a leading biotech and health innovation environment.
- Positive evaluation signal. Participation in the workshop demonstrates the team's proactive and structured approach to project development.
- Strategic and commercialization guidance. Feedback on development strategy, market positioning, regulatory pathway, and investment readiness, helping define clear next steps toward application or market.
About Marco Rüedi
Marco Rüedi (MD, eMBA, eMMM) is a physician, entrepreneur and international business coach with more than 20 years of experience in life sciences and health innovation.
He acts as Senior Business Coach At the Swiss innovation agency Innosuisse, where he advises early- and growth-stage companies in biotech, medtech, pharma and health innovation.
Combining medical training with business and management expertise, he helps teams translate scientific potential into commercially viable development strategies.